EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Myositis-specific antibodies: Overview and clinical utilization

Fatima Halilu, Lisa Christopher-Stine

Rheumatology and Immunology Research · 01.03.2022 · 3 (1) · 1-10

DOI: 10.2478/rir-2022-0001 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Rheumatology and Immunology Research, online erschienen am 20.04.2022. Verfasst von Fatima Halilu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Greater Baltimore Medical Center, Towson, MD, USA. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 107 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose of review—To review autoantibodies associated with different subtypes of idiopathic inflammatory myopathy (IIM) and their clinical applications. IIM are a heterogenous group of autoimmune disorders characterized by muscle weakness, cutaneous features, and internal organ involvement. The diagnosis and classification, which is often challenging, is made using a combination of clinical features, muscle enzyme levels, imaging, and biopsy. The landmark discoveries of novel autoantibodies specific to IIM subtypes have been one of the greatest advancements in the field of myositis. The specificity of these autoantibodies has simplified the diagnostic algorithm of IIM with their heterogenous presentation and outdated the earlier diagnostic criteria. Myositis-specific antibodies (MSAs) have improved diagnostics, clinical phenotyping, and prognostic stratification of the subtypes of IIMs. Furthermore, the levels of certain MSAs correlate with disease activity and muscle enzyme levels such that titers may be able to be used to predict disease course and treatment response.

Schlagwörter

Stichwörter der Autor:innen

anti-synthetase syndromeautoantibodiesdermatomyositisinclusion body myositismyositisnecrotizing myopathy

Autor:innen und Institutionen

  • Department of Medicine, Greater Baltimore Medical Center, Towson, MD, USA.
  • Department of Medicine, Division of Rheumatology, Baltimore, MD, USA.

Zitieren

APA

Halilu, F., & Christopher-Stine, L. (2022). Myositis-specific antibodies: Overview and clinical utilization. Rheumatology and Immunology Research, 3(1), 1-10. https://doi.org/10.2478/rir-2022-0001

Vancouver

Halilu F, Christopher-Stine L. Myositis-specific antibodies: Overview and clinical utilization. Rheumatology and Immunology Research. 2022;3(1):1-10. doi:10.2478/rir-2022-0001

BibTeX
@article{Halilu2022,
  author = {Halilu, Fatima and Christopher-Stine, Lisa},
  title = {Myositis-specific antibodies: Overview and clinical utilization},
  journal = {Rheumatology and Immunology Research},
  year = {2022},
  volume = {3},
  number = {1},
  pages = {1--10},
  doi = {10.2478/rir-2022-0001}
}
Kostenlos starten →